Insider filing · KYMR
Elena Ridloff
Director
profile →
Kymera Therapeutics, Inc.
KYMR · Healthcare · 58 filings in 24 months
ticker →
Elena Ridloff sold $1.0M of Kymera Therapeutics (KYMR)
Executed Mar 31, disclosed Apr 1, 1 day later.
Value, as filed
$1.0M
12,000 sh across 3 lots
Executed
Mar 31
the trade date, as filed
Disclosed
Apr 1
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ERElena Ridloff (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $1.0M of KYMR (12,000 sh across 3 lots, as filed), executed Mar 31.
The name
KYMRHealthcare · Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Elena Ridloff in KYMR
KYMRSALE
Kymera Therapeutics, Inc.
$261K3,000 sh × $87.00
Exec May 11
Filed May 11 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $225K
4,500 sh × $50.00
Exec Jun 11 2025
Filed Jun 11 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $553K
12,000 sh across 2 lots
Exec Jun 3 2025
Filed Jun 3 2025 · 5:30 PM ET